N01DA-4-8306/DA/NIDA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1997	2
1999	2
2000	1
2002	1
2003	2
2004	1
2022	0

1

Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.

Jones RT. Jones RT. NIDA Res Monogr. 1997;175:221-34. NIDA Res Monogr. 1997. PMID: 9467801 Review. No abstract available.

2

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Mendelson J, Jones RT. Mendelson J, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S29-37. doi: 10.1016/s0376-8716(03)00057-7. Drug Alcohol Depend. 2003. PMID: 12738348 Review.

3

The bioavailability of intranasal and smoked methamphetamine.

Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. Harris DS, et al. Clin Pharmacol Ther. 2003 Nov;74(5):475-86. doi: 10.1016/j.clpt.2003.08.002. Clin Pharmacol Ther. 2003. PMID: 14586388 Clinical Trial.

4

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.

Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT. Harris DS, et al. Clin Pharmacokinet. 2004;43(5):329-40. doi: 10.2165/00003088-200443050-00005. Clin Pharmacokinet. 2004. PMID: 15080765 Clinical Trial.

5

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations.

Nath RP, Upton RA, Everhart ET, Cheung P, Shwonek P, Jones RT, Mendelson JE. Nath RP, et al. J Clin Pharmacol. 1999 Jun;39(6):619-23. doi: 10.1177/00912709922008236. J Clin Pharmacol. 1999. PMID: 10354966 Clinical Trial.

6

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine.

Harris DS, Jones RT, Welm S, Upton RA, Lin E, Mendelson J. Harris DS, et al. Drug Alcohol Depend. 2000 Dec 22;61(1):85-94. doi: 10.1016/s0376-8716(00)00126-5. Drug Alcohol Depend. 2000. PMID: 11064186 Clinical Trial.

7

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.

Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Mendelson J, et al. Psychopharmacology (Berl). 1999 Jan;141(1):37-46. doi: 10.1007/s002130050804. Psychopharmacology (Berl). 1999. PMID: 9952063 Clinical Trial.

8

Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.

Everhart ET, Cheung P, Shwonek P, Zabel K, Tisdale EC, Jacob P 3rd, Mendelson J, Jones RT. Everhart ET, et al. Clin Chem. 1997 Dec;43(12):2292-302. Clin Chem. 1997. PMID: 9439446

9

Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry.

Jacob P 3rd, Wilson M, Yu L, Mendelson J, Jones RT. Jacob P 3rd, et al. Anal Chem. 2002 Oct 15;74(20):5290-6. doi: 10.1021/ac020101a. Anal Chem. 2002. PMID: 12403583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results